Cargando…

Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide

BACKGROUND: Virus-like-particles (VLPs) are attractive nanoparticulate scaffolds for broad applications in material/biological sciences and medicine. Prior their functionalization, specific adaptations have to be carried out. These adjustments frequently lead to disordered particles, but the particl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schumacher, Jens, Bacic, Tijana, Staritzbichler, René, Daneschdar, Matin, Klamp, Thorsten, Arnold, Philipp, Jägle, Sabrina, Türeci, Özlem, Markl, Jürgen, Sahin, Ugur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897928/ https://www.ncbi.nlm.nih.gov/pubmed/29653575 http://dx.doi.org/10.1186/s12951-018-0363-0

Ejemplares similares

Generation of fusion protein EGFRvIII-HBcAg and its anti-tumor effect in vivo
por: Duan, Xiao-yi, et al.
Publicado: (2009)

Targeting the tumor vasculature with engineered cystine-knot miniproteins
por: Lui, Bonny Gaby, et al.
Publicado: (2020)

Incidencia de HBcAg en donadores de sangre hospital general de zona No. 32, Minatitlán, Ver.
por: Pérez García, Eduardo
Publicado: (1995)

Parenteral–Oral Immunization with Plant-Derived HBcAg as a Potential Therapeutic Vaccine against Chronic Hepatitis B
por: Pyrski, Marcin, et al.
Publicado: (2019)

Studies on HBcAg-rBlo t 5-21 Fusion Protein Vaccine That Alleviates Blomia tropicalis Airway Inflammation
por: Pei, Yechun, et al.
Publicado: (2022)

Exosomes from Ub‑HBcAg‑overexpressing dendritic cells induce T‑lymphocyte differentiation and enhance cytotoxic T‑lymphocyte activity
por: Yang, Yuhang, et al.
Publicado: (2023)

Negative HBcAg in immunohistochemistry assay of liver biopsy is a predictive factor for the treatment of patients with nucleos(t)ide analogue therapy
por: Huang, Mingxing, et al.
Publicado: (2017)

Intranasal HBsAg/HBcAg-Containing Vaccine Induces Neutralizing Anti-HBs Production in Hepatitis B Vaccine Non-Responders
por: Shiraishi, Kana, et al.
Publicado: (2023)

In vitro expression of precore proteins of hepatitis B virus subgenotype A1 is affected by HBcAg, and can affect HBsAg secretion
por: Deroubaix, Aurélie, et al.
Publicado: (2021)

Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model
por: Chu, Xiaojie, et al.
Publicado: (2016)

Removal of Hepatitis B virus surface HBsAg and core HBcAg antigens using microbial fuel cells producing electricity from human urine
por: Pasternak, Grzegorz, et al.
Publicado: (2019)

Effects of Different Lengths of a Nucleic Acid Binding Region and Bound Nucleic Acids on the Phase Behavior and Purification Process of HBcAg Virus-Like Particles
por: Valentic, Angela, et al.
Publicado: (2022)

Alternative application of an affinity purification tag: hexahistidines in ester hydrolysis
por: Schoonen, Lise, et al.
Publicado: (2017)

The Fusion Protein of CTP-HBcAg18-27-Tapasin Mediates the Apoptosis of CD8(+)T Cells and CD8(+) T Cell Response in HLA-A2 Transgenic Mice
por: Tang, Yu-Yan, et al.
Publicado: (2014)

High-level production of recombinant HBcAg virus-like particles in a mathematically modelled P. pastoris GS115 Mut(+) bioreactor process under controlled residual methanol concentration
por: Bolmanis, Emils, et al.
Publicado: (2022)

Racing for a SARS‐CoV‐2 vaccine
por: Türeci, Özlem, et al.
Publicado: (2021)

Application of In-Situ and Soft-Sensors for Estimation of Recombinant P. pastoris GS115 Biomass Concentration: A Case Analysis of HBcAg (Mut(+)) and HBsAg (Mut(S)) Production Processes under Varying Conditions
por: Grigs, Oskars, et al.
Publicado: (2021)

An active site–tail interaction in the structure of hexahistidine-tagged Thermoplasma acidophilum citrate synthase
por: Murphy, Jesse R., et al.
Publicado: (2015)

Efficient Delivery of Antibodies Intracellularly by Co-Assembly with Hexahistidine-Metal Assemblies (HmA)
por: Wei, Shaoyin, et al.
Publicado: (2021)

Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics
por: Niu, Qiang, et al.
Publicado: (2022)

Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B: 2-Year Follow-Up of Phase III Clinical Trial
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2021)

Structural and functional comparison of hexahistidine tagged and untagged forms of small multidrug resistance protein, EmrE
por: Qazi, S. Junaid S., et al.
Publicado: (2015)

Selective activation of tumor growth-promoting Ca(2+ )channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2
por: Koslowski, Michael, et al.
Publicado: (2009)

Retrieval of functional TCRs from single antigen-specific T cells: Toward individualized TCR-engineered therapies
por: Omokoko, Tana, et al.
Publicado: (2015)

Targeting the tumor mutanome for personalized vaccination therapy
por: Kreiter, Sebastian, et al.
Publicado: (2012)

Development of a hexahistidine-3× FLAG-tandem affinity purification method for endogenous protein complexes in Pichia pastoris
por: Higo, Toshiaki, et al.
Publicado: (2014)

Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)
por: Huber, Bettina, et al.
Publicado: (2017)

Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates
por: Kazaks, Andris, et al.
Publicado: (2017)

Optimization of a Soft Ensemble Vote Classifier for the Prediction of Chimeric Virus-Like Particle Solubility and Other Biophysical Properties
por: Vormittag, Philipp, et al.
Publicado: (2020)

Self-assembly of hexahistidine-tagged tobacco etch virus capsid protein into microfilaments that induce IgG2-specific response against a soluble porcine reproductive and respiratory syndrome virus chimeric protein
por: Manuel-Cabrera, Carlos Alberto, et al.
Publicado: (2016)

Ensembles of Hydrophobicity Scales as Potent Classifiers for Chimeric Virus-Like Particle Solubility – An Amino Acid Sequence-Based Machine Learning Approach
por: Vormittag, Philipp, et al.
Publicado: (2020)

Molecular Characterization of Virus-induced Autoantibody Responses
por: Ludewig, Burkhard, et al.
Publicado: (2004)

NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells
por: Wagner, Meike, et al.
Publicado: (2013)

Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination
por: Vormehr, Mathias, et al.
Publicado: (2015)

Comparison of Claudin 18.2 expression in primary tumors and lymph node metastases in Japanese patients with gastric adenocarcinoma
por: Rohde, Christoph, et al.
Publicado: (2019)

Beam position for the 2m HBC
por: Perreau, J M, et al.
Publicado: (1964)

Report on the future program for the HBC 200
por: CERN. Geneva. Track Chamber Committee
Publicado: (1975)

Memorandum : HBC 200 Camera Window
por: Stierlin, R G, et al.
Publicado: (1975)

Geometry titles for the 2m HBC
por: Kellner, G
Publicado: (1969)

Isolated Anti-HBc: Significance and Management
por: MORETTO, Florian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6vce7drhsu1fl3bbbuph2c0j8o